March 26 (Reuters) - Teva Pharmaceutical Industries Ltd :
* VANDA PHARMACEUTICALS - ON MARCH 23, GOT PARAGRAPH IV CERTIFICATION NOTICE LETTER REGARDING ANDA BY TEVA FOR GENERIC VERSION OF 20MG HETLIOZ CAPSULE
* VANDA SAYS IN LETTER, TEVA ALLEGES SOME PATENTS WILL NOT BE INFRINGED BY ITS USE OR SALE OF 20MG HETLIOZ - SEC FILING Source text (bit.ly/2pFMoh0) Further company coverage: